MMP9 and cancer: Regarding cancer biomarkers, Ki67, MMP2, and MMP9 protein levels were decreased by SAMD5 but increased by PLK1; PLK1 overexpression significantly alleviated the inhibitory effects of SAMD5 on these factors (Figures 9F-9G).